Pneumococcal vaccine - Millenium Biologix

Drug Profile

Pneumococcal vaccine - Millenium Biologix

Alternative Names: Streptococcus pneumoniae vaccine - Millenium Biologix

Latest Information Update: 02 Jun 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Millenium Biologix Corporation
  • Class Pneumococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pneumococcal infections

Most Recent Events

  • 06 Dec 2004 Millenium Biologix has merged with Cytovax Biotechnologies to form Millenium Biologix Corporation
  • 16 Jun 2003 This programme is still in active development
  • 05 Nov 2001 Preclinical development for Pneumococcal infections in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top